Carbon Neutrality to ISO 14068-1 and Credible Climate Claims

Carbon Neutrality to ISO 14068-1 and Credible Climate Claims
Product Description

Positive Organizations supports pharmaceutical companies that want to make a carbon neutrality claim and have it stand up to scrutiny.


The rules changed. From 27 September 2026, Directive (EU) 2024/825 on empowering consumers for the green transition prohibits product claims such as carbon neutral, climate neutral or net zero product when they rest on greenhouse gas offsetting outside the value chain. Claims based on measured reductions within the value chain remain permitted.


We therefore build neutrality the defensible way: a complete GHG inventory, a genuine reduction plan first, and only then careful selection of certified credits for the documented residual.


Organisational carbon neutrality is then certified under ISO 14068-1, with the claim, boundary and residual clearly evidenced.

Positive Organizations

  • Country/Region:
    Switzerland
  • On CPHI since:
    2026
  • Certificates:
    1
  • Employees:
    1 - 24
Company types
Consultancy
Primary activities
Other
Regulatory Affairs
Specifications
  • Details
    Standards: ISO 14068-1 climate change management, transition to net zero, carbon neutrality; GHG Protocol; ISO 14064-1; Directive (EU) 2024/825 (EmpCo), applicable from 27 September 2026; ISO 14021 self-declared claims.


    Scope: GHG inventory and boundary definition for the neutrality subject; reduction plan and implementation hierarchy with reductions prioritised over compensation; residual emissions quantification; due diligence and selection of certified carbon credits, including permanence, additionality and co-benefit review; ISO 14068-1 carbon neutrality certification support; claim wording review against EU consumer protection rules and greenwashing risk.


    Application areas: pharma and biotech manufacturers, CDMOs, API and packaging suppliers, and any company making climate claims on products, sites, events or corporate communications in the EU market.
  • Selling Points
    Green Product; International Approvals/Standards; Quality Service; - Claim wording reviewed against the EmpCo Directive before you publish it
    - Reduction first, offsetting only for the documented residual
    - ISO 14068-1 certification pathway, the recognised successor to PAS 2060
    - Carbon credit due diligence on permanence, additionality and co-benefits
    - Protects marketing, procurement and legal from greenwashing exposure
    - Swiss and EU regulatory perspective in one team
  • Supplied from
    Switzerland

Positive Organizations

  • Country/Region:
    Switzerland
  • On CPHI since:
    2026
  • Certificates:
    1
  • Employees:
    1 - 24
Company types
Consultancy
Primary activities
Other
Regulatory Affairs

More Products from Positive Organizations (10)

  • Circular Economy, Resource Efficiency and Reffnet Consultancy

    Product Circular Economy, Resource Efficiency and Reffnet Consultancy

    Positive Organizations helps pharmaceutical manufacturers and packaging suppliers cut material and resource losses and build a credible circularity position.


    We map resource and material flows across your processes, visualise them with Sankey diagrams, benchmark efficiency against comparable ope...
  • Corporate Carbon Footprint, Decarbonization and Energy Assessment

    Product Corporate Carbon Footprint, Decarbonization and Energy Assessment

    Positive Organizations calculates your corporate carbon footprint, a greenhouse gas inventory covering Scope 1, Scope 2 and material Scope 3 categories, and then turns it into a reduction plan.


    At least 55 percent of pharmaceutical emissions sit in Scope 3, and manufacturing accounts for the maj...
  • EcoVadis, CDP and S&P CSA Rating Support and Gap Analysis

    Product EcoVadis, CDP and S&P CSA Rating Support and Gap Analysis

    Positive Organizations is an EcoVadis Accredited Consulting Partner and Approved Training Partner, and improves the ratings your pharmaceutical customers use to screen suppliers.


    EcoVadis scores you from 0 to 100 across Environment, Labor and Human Rights, Ethics and Sustainable Procurement, jud...
  • ESG Governance, Policies, Training, DEI and Leadership Coaching

    Product ESG Governance, Policies, Training, DEI and Leadership Coaching

    Positive Organizations puts the governance layer in place that ESG ratings, auditors and customers all look for, and then makes it live in the organisation.


    We draft the ESG documentation suite: whistleblower policy and reporting channel, code of conduct, code of ethics, human rights, anti-corru...
  • ESG Strategy, Materiality and Risk Assessment for Pharma

    Product ESG Strategy, Materiality and Risk Assessment for Pharma

    Positive Organizations builds the ESG strategy that sits underneath everything else, so your reporting, ratings and customer questionnaires draw on one coherent plan instead of ad hoc answers.


    We begin with an ESG maturity assessment and a peer benchmark against comparable pharmaceutical manufac...
  • ESG Supply Chain Due Diligence and Supplier Assessment

    Product ESG Supply Chain Due Diligence and Supplier Assessment

    Positive Organizations builds the supplier ESG due diligence system that pharmaceutical procurement now requires, and that upstream regulation increasingly assumes.


    Around 55 percent or more of pharmaceutical emissions and most human rights exposure sit with suppliers, and 69 percent of pharma l...
  • ISO Certifications and B Corp Certification Support

    Product ISO Certifications and B Corp Certification Support

    Positive Organizations takes pharmaceutical companies and suppliers through management system certification and B Corp certification, from gap analysis to certificate.


    We support ISO 14001 environmental management, ISO 50001 energy management, ISO 45001 occupational health and safety, ISO 20121 ...
  • Life-Cycle Assessment and Product Carbon Footprint for Pharma

    Product Life-Cycle Assessment and Product Carbon Footprint for Pharma

    Positive Organizations conducts product and process life-cycle assessments to ISO 14040 and ISO 14044, quantifying the environmental impact of an API, a formulation, a device or a packaging system from raw material to end of life.


    In pharmaceutical manufacturing the impact is concentrated upstre...
  • PPWR Readiness Assessment for Pharma Packaging

    Product PPWR Readiness Assessment for Pharma Packaging

    Regulation (EU) 2025/40 (PPWR) has applied across the EU-27 since 12 August 2026. For pharma the exposure is uneven: primary packaging of medicinal products is exempt from the recyclability and recycled-content targets — but that exemption has to be documented, and secondary, transport and e-commerce packa...
  • Sustainability Reporting: GRI, CSRD and ESRS, plus ESG Data Management

    Product Sustainability Reporting: GRI, CSRD and ESRS, plus ESG Data Management

    Positive Organizations produces GRI-aligned and CSRD-compliant sustainability reports for pharmaceutical companies and their suppliers.


    Following the Omnibus I Directive (EU) 2026/470, mandatory ESRS reporting now applies to undertakings with more than 1,000 employees and over EUR 450 million tu...